This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regents of the University of Minnesota. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Robert Harrison Hullsiek
Introduction
Robert Harrison Hullsiek is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical treatments, particularly through his innovative patent. His work is associated with the Regents of the University of Minnesota, where he continues to advance research and development.
Latest Patents
Robert Harrison Hullsiek holds a patent titled "Treatments Administering Chimeric IgG Fc Receptor Comprising an Extracellular Domain of CD64." This patent represents a crucial advancement in therapeutic methods, showcasing his commitment to improving healthcare solutions. He has 1 patent to his name, reflecting his innovative contributions to the field.
Career Highlights
Throughout his career, Hullsiek has focused on developing treatments that leverage advanced biological mechanisms. His work at the Regents of the University of Minnesota has positioned him as a key figure in medical research, contributing to the understanding and application of chimeric receptors in therapy.
Collaborations
Robert has collaborated with esteemed colleagues such as Jianming Wu and Bruce Kenneth Walcheck. These partnerships have enhanced his research efforts and expanded the impact of his innovations in the medical field.
Conclusion
Robert Harrison Hullsiek exemplifies the spirit of innovation in medical research. His contributions through patents and collaborations continue to influence the development of effective treatments. His work at the Regents of the University of Minnesota highlights the importance of academic research in advancing healthcare solutions.